Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Relapse Prevention With Varenicline
NCT00944554Phase 4Completed
- Sponsor
- Johns Hopkins University
- Start
- Oct 2008
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in nicotine dependence comparing Varenicline with Placebo (2 arms). Primary endpoint: Days to Relapse at 4 weeks. Started Oct 2008; status: completed.
02
Drugs
varenicline
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT00944554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00944554.